Biotech company Pebble Labs is harnessing bacteria to block the transmission of virulent shrimp diseases in a process known as RNA interference, or RNAi.
Massachusetts-based biotechnology firm KnipBio is the first single-cell protein manufacturer serving the aquafeed industry to earn Generally Regarded as Safe designation from the U.S. Food and Drug Administration.
At the Global Aquaculture Alliance’s annual GOAL conference in Guyaquil, Ecuador, unfamiliar topics gave aquaculture industry leaders something to chew on.
Biotechnology firm NovoNutrients aims to produce a line of nutraceutical aquafeed additives as well as a bulk feed ingredient that can supplement fishmeal. Its process includes feeding carbon dioxide from industrial gas to a “microbial consortium” starring hydrogen-oxidizing bacteria.
MicroSynbiotiX is employing the power of transgenic microalgae to make it cheaper and easier for aquaculture producers to administer vaccines to fish.
Scottish biotech firm Fixed Phage aims to bottle the powers of bacteriophages to deploy these “bacteria killers” on some of the world’s most destructive aquaculture diseases.
Initially, a new chip loaded with oyster DNA pieces will identify oysters resistant to the herpes virus, but in the future it may be able to identify oysters with other desirable characteristics, such as faster growth rates.
KnipBio, a Massachusetts-based biotechnology startup founded in 2013, is refining the manufacturing process for a promising aquaculture feed ingredient that may one day form the foundation of the food that farmed fish eat.